Death in phase I cannabinoid? [Off Topic]

posted by Ohlbe – France, 2016-01-18 10:58 (3799 d 08:49 ago) – Posting: # 15835
Views: 50,832

Dear all,

❝ “Marisol Touraine, the French health minister, later said that the pill did not contain cannabis or its derivatives but acted on the body’s endocannabinoid system.”


According to information in the French press, quoting the sponsor, the compound is an inhibitor of the Fatty Acid Amide Hydrolase (FAAH), which metabolises endocannabinoids.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
102 visitors (0 registered, 102 guests [including 18 identified bots]).
Forum time: 20:47 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5